Media Room


[Industry Voice #5] Clinical Trials during COVID-19. An Investigator's Outlook

While the clinical trials industry has been working vigorously to find ways to navigate through COVID-19-imposed challenges, our own experience also tells us that many investigators have been facing even harder times. 

In order to evaluate the situation, OCT Clinical interviewed Karina Khidishyan, MD, an investigator at one of the largest oncology sites in the country, the FSBI Petrov Research Institute of Oncology of the Ministry of Health of Russia.

You can read the written version of the interview here.